Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La RochefiledCriticalHoffmann La Roche
Publication of UY27194A1publicationCriticalpatent/UY27194A1/en
Esta invención se refiere a los compuestos que son generalmente antagonistas del receptor IP y que están representados por la fórmula general I en donde G1 es seleccionado de los grupos a, b1 y b2; y A y G2 son tal como se han definido en la especificación; o isómeros individuales, mezclas racémicas o no racémicas de isómeros, o sales o solvatos farmacéuticamente aceptables de los mismos. La invención además se refiere a composiciones farmacéuticas que contienen dichos compuestos, su uso como agentes terapéuticos, y los métodos de la preparación de los mismos.This invention relates to compounds that are generally IP receptor antagonists and that are represented by the general formula I wherein G1 is selected from groups a, b1 and b2; and A and G2 are as defined in the specification; or individual isomers, racemic or non-racemic mixtures of isomers, or pharmaceutically acceptable salts or solvates thereof. The invention also relates to pharmaceutical compositions containing said compounds, their use as therapeutic agents, and the methods of preparing them.
UY27194A2001-03-022002-03-01
DERIVATIVES OF ALCOXICARBONILAMINOTETRAZOLIL PHENYLL OR BENZOIC ALCOXICARBONYLAMINE ACID AS ANTAGONIST OF P.
UY27194A1
(en)
DERIVATIVES OF THE ALCOXICARBONILAMINO-HETEROARILCARBOXILICO ACID, ITS USE, A PROCEDURE TO PREPARE THEM AND PHARMACEUTICAL COMPOSITIONS THAT UNDERSTAND THEM
BENZISOXAZOLES AND PHENONES AS ALFA-2-ANTAGONISTS, A PROCESS FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS AND THE USE OF THE SAME FOR THE MANUFACTURE OF A MEDICINAL PRODUCT.